Quartuccio Michael, Hall Erica, Singh Vikesh, Makary Martin A, Hirose Kenzo, Desai Niraj, Walsh Christi, Warren Daniel, Sun Zhaoli, Stein Ellen, Kalyani Rita R
Division of Endocrinology, Diabetes and Metabolism.
Division of Gastroenterology and Hepatology.
J Clin Endocrinol Metab. 2017 Mar 1;102(3):801-809. doi: 10.1210/jc.2016-2952.
Total pancreatectomy with islet auto transplantation (TPIAT) is a treatment for medically refractory chronic pancreatitis that can prevent postsurgical diabetes in some patients. Predictors of insulin independence are needed for appropriate patient selection and counseling.
To explore glycemic predictors of insulin independence after TPIAT.
A prospective cohort of patients.
We investigated 34 patients undergoing TPIAT from 2011-2016 at Johns Hopkins Hospital, all had a 75-g oral glucose tolerance test (OGTT) administered prior to their TPIAT. The primary outcome was insulin independence 1 year after TPIAT.
Ten of 34 (29%) patients were insulin independent 1 year after TPIAT. All patients with impaired fasting glucose and/or impaired glucose tolerance preoperatively were insulin dependent at 1 year. In age-adjusted regression analyses, fasting glucose ≤ 90 mg/dL [odds ratio (OR) = 6.56; 1.11 to 38.91; P = 0.04], 1-hour OGTT glucose ≤ 143 mg/dL (OR = 6.65; 1.11 to 39.91; P = 0.04), and 2-hour OGTT glucose ≤ 106 mg/dL (OR = 11.74; 1.46 to 94.14; P = 0.02) were significant predictors of insulin independence. In receiver operating characteristic analyses, homeostatic model assessment of β-cell function (HOMA-β) was the most robust predictor of insulin independence [area under the curve (AUC) = 0.88; 0.73 to 1.00].
Normal preoperative glucose status and lower fasting and postchallenge OGTT glucose values are significant predictors of insulin independence after TPIAT. Higher islet function (HOMA-β) was the strongest predictor. OGTT testing may be a useful tool to aid in patient counseling prior to TPIAT and should be further investigated.
全胰切除术联合胰岛自体移植(TPIAT)是治疗药物难治性慢性胰腺炎的一种方法,可预防部分患者术后糖尿病。为了进行恰当的患者选择和咨询,需要了解胰岛素非依赖的预测因素。
探讨TPIAT术后胰岛素非依赖的血糖预测因素。
对患者进行前瞻性队列研究。
我们调查了2011年至2016年在约翰霍普金斯医院接受TPIAT的34例患者,所有患者在TPIAT前均进行了75克口服葡萄糖耐量试验(OGTT)。主要结局是TPIAT术后1年胰岛素非依赖。
34例患者中有10例(29%)在TPIAT术后1年胰岛素非依赖。术前空腹血糖受损和/或糖耐量受损的所有患者在1年时均依赖胰岛素。在年龄校正回归分析中,空腹血糖≤90mg/dL[比值比(OR)=6.56;1.11至38.91;P=0.04]、OGTT 1小时血糖≤143mg/dL(OR=6.65;1.11至39.91;P=0.04)和OGTT 2小时血糖≤106mg/dL(OR=11.74;1.46至94.!14;P=0.02)是胰岛素非依赖的显著预测因素。在受试者工作特征分析中,β细胞功能的稳态模型评估(HOMA-β)是胰岛素非依赖的最强预测因素[曲线下面积(AUC)=0.88;0.73至1.00]。
术前正常血糖状态以及较低的空腹和OGTT激发后血糖值是TPIAT术后胰岛素非依赖的显著预测因素。较高的胰岛功能(HOMA-β)是最强的预测因素。OGTT检测可能是TPIAT前辅助患者咨询的有用工具,应进一步研究。